Literature DB >> 29348474

Adrenal disease: Imitating the cortisol profile improves the immune system.

Lisa Müller1, Marcus Quinkler1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29348474     DOI： 10.1038/nrendo.2018.5

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  10 in total

1.  Improvement of anthropometric and metabolic parameters, and quality of life following treatment with dual-release hydrocortisone in patients with Addison's disease.

Authors:  Roberta Giordano; Federica Guaraldi; Elisa Marinazzo; Federica Fumarola; Alessia Rampino; Rita Berardelli; Ioannis Karamouzis; Manuela Lucchiari; Tilde Manetta; Giulio Mengozzi; Emanuela Arvat; Ezio Ghigo
Journal:  Endocrine       Date:  2015-07-17       Impact factor: 3.633

2.  Dehydroepiandrosterone replacement in patients with Addison's disease has a bimodal effect on regulatory (CD4+CD25hi and CD4+FoxP3+) T cells.

Authors:  Alasdair J Coles; Sara Thompson; Amanda L Cox; Suzanne Curran; Elli M Gurnell; V Krishna Chatterjee
Journal:  Eur J Immunol       Date:  2005-12       Impact factor: 5.532

3.  Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation.

Authors:  G Johannsson; A G Nilsson; R Bergthorsdottir; P Burman; P Dahlqvist; B Ekman; B E Engström; T Olsson; O Ragnarsson; M Ryberg; J Wahlberg; B M K Biller; J P Monson; P M Stewart; H Lennernäs; S Skrtic
Journal:  J Clin Endocrinol Metab       Date:  2011-11-23       Impact factor: 5.958

4.  Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial.

Authors:  Andrea M Isidori; Mary Anna Venneri; Chiara Graziadio; Chiara Simeoli; Daniela Fiore; Valeria Hasenmajer; Emilia Sbardella; Daniele Gianfrilli; Carlotta Pozza; Patrizio Pasqualetti; Stefania Morrone; Angela Santoni; Fabio Naro; Annamaria Colao; Rosario Pivonello; Andrea Lenzi
Journal:  Lancet Diabetes Endocrinol       Date:  2017-12-08       Impact factor: 32.069

5.  Modified-release hydrocortisone decreases BMI and HbA1c in patients with primary and secondary adrenal insufficiency.

Authors:  Marcus Quinkler; Roy Miodini Nilsen; Kathrin Zopf; Manfred Ventz; Marianne Øksnes
Journal:  Eur J Endocrinol       Date:  2015-02-05       Impact factor: 6.664

6.  Optimizing glucocorticoid replacement therapy in severely adrenocorticotropin-deficient hypopituitary male patients.

Authors:  Lucy-Ann Behan; Bairbre Rogers; Mark J Hannon; Patrick O'Kelly; William Tormey; Diarmuid Smith; Christopher J Thompson; Amar Agha
Journal:  Clin Endocrinol (Oxf)       Date:  2011-10       Impact factor: 3.478

7.  Continuous subcutaneous hydrocortisone infusion versus oral hydrocortisone replacement for treatment of addison's disease: a randomized clinical trial.

Authors:  Marianne Oksnes; Sigridur Björnsdottir; Magnus Isaksson; Paal Methlie; Siri Carlsen; Roy M Nilsen; Jan-Erik Broman; Kai Triebner; Olle Kämpe; Anna-Lena Hulting; Sophie Bensing; Eystein S Husebye; Kristian Løvås
Journal:  J Clin Endocrinol Metab       Date:  2014-02-11       Impact factor: 5.958

8.  Prednisolone is associated with a worse lipid profile than hydrocortisone in patients with adrenal insufficiency.

Authors:  Marcus Quinkler; Bertil Ekman; Claudio Marelli; Sharif Uddin; Pierre Zelissen; Robert D Murray
Journal:  Endocr Connect       Date:  2016-11-18       Impact factor: 3.335

9.  Primary adrenal insufficiency is associated with impaired natural killer cell function: a potential link to increased mortality.

Authors:  Irina Bancos; Jon Hazeldine; Vasileios Chortis; Peter Hampson; Angela E Taylor; Janet M Lord; Wiebke Arlt
Journal:  Eur J Endocrinol       Date:  2017-04       Impact factor: 6.664

10.  The modulation of corticosteroid metabolism by hydrocortisone therapy in patients with hypopituitarism increases tissue glucocorticoid exposure.

Authors:  Mark Sherlock; Lucy Ann Behan; Mark J Hannon; Aurora Aragon Alonso; Christopher J Thompson; Robert D Murray; Nicola Crabtree; Beverly A Hughes; Wiebke Arlt; Amar Agha; Andrew A Toogood; Paul M Stewart
Journal:  Eur J Endocrinol       Date:  2015-08-11       Impact factor: 6.664
  10 in total
  4 in total

1.  Cesarean delivery and infant cortisol regulation.

Authors:  Leticia D Martinez; Laura M Glynn; Curt A Sandman; Deborah A Wing; Elysia Poggi Davis
Journal:  Psychoneuroendocrinology       Date:  2020-10-02       Impact factor: 4.905

2.  Unpredictable maternal behavior is associated with a blunted infant cortisol response.

Authors:  Amanda N Noroña-Zhou; Alyssa Morgan; Laura M Glynn; Curt A Sandman; Tallie Z Baram; Hal S Stern; Elysia Poggi Davis
Journal:  Dev Psychobiol       Date:  2020-03-01       Impact factor: 3.038

3.  Increased Infection Risk in Addison's Disease and Congenital Adrenal Hyperplasia.

Authors:  Alberto S Tresoldi; Dana Sumilo; Mary Perrins; Konstantinos A Toulis; Alessandro Prete; Narendra Reddy; John A H Wass; Wiebke Arlt; Krishnarajah Nirantharakumar
Journal:  J Clin Endocrinol Metab       Date:  2020-02-01       Impact factor: 5.958

Review 4.  Current evidence on the impact of the COVID-19 pandemic on paediatric endocrine conditions.

Authors:  Margherita Gnocchi; Tiziana D'Alvano; Claudia Lattanzi; Giulia Messina; Maddalena Petraroli; Viviana D Patianna; Susanna Esposito; Maria E Street
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-05       Impact factor: 6.055
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.